MCM
IDXX icon

Mitchell Capital Management’s Idexx Laboratories IDXX Stock Holding History

Mitchell Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-445
Closed -$225K – 112
2024
Q3 		$225K Hold
445
– – 0.04% 103
2024
Q2 		$217K Sell
445
-266
-37% -$134K 0.04% 115
2024
Q1 		$384K Sell
711
-5,665
-89% -$3.1M 0.07% 102
2023
Q4 		$3.54M Buy
6,376
+4
+0.1% +$1.88K 0.75% 48
2023
Q3 		$2.79M Buy
6,372
+79
+1% +$39.4K 0.66% 55
2023
Q2 		$3.16M Buy
6,293
+32
+0.5% +$15.3K 0.72% 54
2023
Q1 		$3.13M Buy
6,261
+96
+2% +$45.9K 0.78% 53
2022
Q4 		$2.52M Buy
6,165
+34
+0.6% +$13.2K 0.7% 54
2022
Q3 		$2M Buy
6,131
+4
+0.1% +$1.47K 0.57% 63
2022
Q2 		$2.15M Sell
6,127
-2,996
-33% -$1.22M 0.6% 58
2022
Q1 		$4.99M Buy
9,123
+95
+1% +$50K 1.12% 20
2021
Q4 		$5.95M Sell
9,028
-493
-5% -$309K 1.2% 20
2021
Q3 		$5.92M Sell
9,521
-171
-2% -$115K 1.33% 15
2021
Q2 		$6.12M Sell
9,692
-116
-1% -$64.1K 1.34% 13
2021
Q1 		$4.8M Sell
9,808
-2,412
-20% -$1.21M 1.17% 21
2020
Q4 		$6.11M Sell
12,220
-223
-2% -$99.8K 1.53% 13
2020
Q3 		$4.89M Sell
12,443
-164
-1% -$60.6K 1.42% 17
2020
Q2 		$4.16M Sell
12,607
-172
-1% -$49.8K 1.34% 16
2020
Q1 		$3.1M Buy
12,779
+667
+6% +$174K 1.21% 22
2019
Q4 		$3.16M Sell
12,112
-552
-4% -$145K 1.01% 31
2019
Q3 		$3.44M Sell
12,664
-388
-3% -$108K 1.16% 27
2019
Q2 		$3.59M Sell
13,052
-7,399
-36% -$1.82M 1.21% 25
2019
Q1 		$4.57M Buy
20,451
+1,173
+6% +$242K 1.62% 20
2018
Q4 		$3.59M Sell
19,278
-182
-0.9% -$37.3K 1.52% 23
2018
Q3 		$4.86M Buy
19,460
+797
+4% +$193K 1.58% 26
2018
Q2 		$4.07M Sell
18,663
-713
-4% -$147K 1.47% 30
2018
Q1 		$3.71M Buy
+19,376
New +$3.58M 1.34% 34

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Mitchell Capital Management's IDXX Position: Q4 2024 in Review

Mitchell Capital Management sold out of Idexx Laboratories (IDXX) in Q4 2024, closing a stake of 445 shares — an estimated $225K sold.

Mitchell Capital Management first reported a position in IDXX in Q1 2018 and held it in 27 quarters. The position peaked at $6.12M in Q2 2021. 1,124 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

  • Mitchell Capital Management reported no remaining Idexx Laboratories position as of Q4 2024 after selling out during the quarter.
  • Mitchell Capital Management sold 445 Idexx Laboratories shares in Q4 2024, an estimated $225K.
  • Mitchell Capital Management first reported a position in Idexx Laboratories in Q1 2018 and held it in 27 quarters.
  • Mitchell Capital Management's Idexx Laboratories position peaked at $6.12M in Q2 2021.
  • 1,124 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on Mitchell Capital Management's 13F filing for Q4 2024, filed 5 Feb 2025.